Sarda Proteins Ltd
Sarda Proteins Ltd (SARDAPROTEINSLTD): company summary
The company's revenue surged 1760.8% annually, but net profit remained at ₹0 crore, with a net profit margin of 0.0%.
Sarda Proteins Ltd (SARDAPROTEINSLTD) is a micro-cap FMCG company valued at ₹143 crore operating in FMCG Products on the NSE and BSE.
- Recent price move
- Sarda Proteins Ltd last traded at ₹156.15, modestly down 1.98% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit of ₹2 crore for the latest quarter, marking a swing from a net loss of ₹0 crore in the same quarter a year earlier. The promoter holding increased to 80.66% as of 2026-06-30, up by 80.66 percentage points from the previous quarter.
- Financial performance
- The company's revenue surged 1760.8% annually, but net profit remained at ₹0 crore, with a net profit margin of 0.0%. The latest quarter showed a swing from a net loss of ₹0 crore to a profit of ₹2 crore, while revenue rose 18.6% compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 2602.5 times earnings, 10.15 times book value.
- Things to watch
- The company is not paying out dividends despite reporting profits. The net profit margin fell to 0.0% from 1.5% in the prior year. The stock is 18.5% below its 52-week high.
- Where it stands
- The company reported a net profit of ₹2 crore in the latest quarter, up from a net loss of ₹0 crore a year earlier. The stock is 18.5% below its 52-week high, and the promoter holding increased to 80.66% as of 2026-06-30.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by momentum (7.5), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.05
- Strong returns on equity (24%)
- Valuation is weak (0.0/10)
- Expensive at 200× earnings
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More FMCG stocks · FMCG Products
Explore Sarda Proteins Ltd’s valuation
Free deep-dive tools · no sign-up
Sarda Proteins Ltd peers in FMCG
Other FMCG stocks on the NSE & BSE. See the full FMCG sector list.
Related tools & concepts
Value Sarda Proteins Ltd with the ratios and calculators DocStoX uses in its analysis.

